Literature DB >> 17598055

Who is treated, and how, for depression? An analysis of statutory health insurance data in Germany.

Anke Bramesfeld1, Thomas Grobe, Friedrich Wilhelm Schwartz.   

Abstract

BACKGROUND: Studies on the treatment of depression using epidemiological survey methods suggest a high level of under-treatment. Little is known about the characteristics of those people receiving treatment and indeed what kind of treatment they are likely to receive.
METHOD: Analysis of the data of a statutory health insurance company in Germany.
RESULTS: In middle-aged groups, about 50% of those diagnosed as being depressed in outpatient care are prescribed antidepressants and/or psychotherapy in the course of a year. There is more pharmacologic treatment provided in rural areas and more psychotherapy in cities, suggesting that treatment is dependent upon service availability rather than evidence-based treatment decisions. Treatment rates are considerably lower in the very young and the very old and show gender bias. Young females receive less pharmacologic treatment than young males, and elderly men are, in general, treated less than women, suggesting under-treatment at least for these groups.
CONCLUSIONS: The low treatment rates following the diagnosis of depression in the young and the old require attention, in particular with respect to gender aspect.

Entities:  

Mesh:

Year:  2007        PMID: 17598055     DOI: 10.1007/s00127-007-0225-9

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  22 in total

1.  The association between age and depression in the general population: a multivariate examination.

Authors:  E Stordal; A Mykletun; A A Dahl
Journal:  Acta Psychiatr Scand       Date:  2003-02       Impact factor: 6.392

2.  [The direct costs of depressive disorders in Germany].

Authors:  Susanne Friemel; Sebastian Bernert; Matthias C Angermeyer; Hans-Helmut König
Journal:  Psychiatr Prax       Date:  2005-04

3.  Influence of socio-economic deprivation on the prevalence and outcome of depression in primary care: the Hampshire Depression Project.

Authors:  K Ostler; C Thompson; A L Kinmonth; R C Peveler; L Stevens; A Stevens
Journal:  Br J Psychiatry       Date:  2001-01       Impact factor: 9.319

4.  Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

5.  Long term outcomes from the IMPACT randomised trial for depressed elderly patients in primary care.

Authors:  Enid M Hunkeler; Wayne Katon; Lingqi Tang; John W Williams; Kurt Kroenke; Elizabeth H B Lin; Linda H Harpole; Patricia Arean; Stuart Levine; Lydia M Grypma; William A Hargreaves; Jürgen Unützer
Journal:  BMJ       Date:  2006-01-20

6.  [Affective, somatoform and anxiety disorders in Germany--initial results of an additional federal survey of "psychiatric disorders"].

Authors:  H U Wittchen; N Müller; H Pfister; S Winter; B Schmidtkunz
Journal:  Gesundheitswesen       Date:  1999-12

7.  Using epidemiological data to model efficiency in reducing the burden of depression*

Authors:  Gavin Andrews; Kristy Sanderson; Justine Corry; Helen M. Lapsley
Journal:  J Ment Health Policy Econ       Date:  2000-12-01

8.  Antidepressant use in children and adolescents in Germany.

Authors:  Jörg M Fegert; M Kölch; Julie Magno Zito; Gerd Glaeske; Katrin Janhsen
Journal:  J Child Adolesc Psychopharmacol       Date:  2006 Feb-Apr       Impact factor: 2.576

9.  Measuring quality of pharmacotherapy for depression in a national health care system.

Authors:  Susan H Busch; Doug Leslie; Robert Rosenheck
Journal:  Med Care       Date:  2004-06       Impact factor: 2.983

10.  Who is diagnosed as suffering from depression in the German statutory health care system? An analysis of health insurance data.

Authors:  Anke Bramesfeld; Thomas G Grobe; Friedrich Wilhelm Schwartz
Journal:  Eur J Epidemiol       Date:  2007-05-05       Impact factor: 12.434

View more
  10 in total

1.  Gender disparities in the pharmacological treatment of cardiovascular disease and diabetes mellitus in the very old: an epidemiological, cross-sectional survey.

Authors:  Jon Brännström; Katarina Hamberg; Lena Molander; Hugo Lövheim; Yngve Gustafson
Journal:  Drugs Aging       Date:  2011-12-01       Impact factor: 3.923

2.  Who receives depression-specific treatment? A secondary data-based analysis of outpatient care received by over 780,000 statutory health-insured individuals diagnosed with depression.

Authors:  Stefanie Boenisch; Rueya-Daniela Kocalevent; Herbert Matschinger; Roland Mergl; Claudia Wimmer-Brunauer; Martin Tauscher; Dietmar Kramer; Ulrich Hegerl; Anke Bramesfeld
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-02-25       Impact factor: 4.328

3.  Predictors of prescribed medication use for depression, anxiety, stress, and sleep problems in mid-aged Australian women.

Authors:  Margot J Schofield; Asaduzzaman Khan
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-06-07       Impact factor: 4.328

4.  Screening for depression in the older long-term unemployed.

Authors:  Iris Liwowsky; Dietmar Kramer; Roland Mergl; Anke Bramesfeld; Antje-Kathrin Allgaier; Ernst Pöppel; Ulrich Hegerl
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-12-01       Impact factor: 4.328

5.  Prevalence of depression diagnosis and prescription of antidepressants in East and West Germany: an analysis of health insurance data.

Authors:  Anke Bramesfeld; Thomas Grobe; Friedrich Wilhelm Schwartz
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-05-19       Impact factor: 4.328

6.  Differences in healthcare costs in youths with conduct disorders in rural vs. urban regions: an analysis of German health insurance data.

Authors:  Heike Gerhardt; Monika Heinzel-Gutenbrunner; Christian J Bachmann
Journal:  BMC Health Serv Res       Date:  2018-09-14       Impact factor: 2.655

7.  Time trends in depression prevalence and health-related correlates: results from population-based surveys in Germany 1997-1999 vs. 2009-2012.

Authors:  Julia Bretschneider; Silke Janitza; Frank Jacobi; Julia Thom; Ulfert Hapke; Tobias Kurth; Ulrike E Maske
Journal:  BMC Psychiatry       Date:  2018-12-20       Impact factor: 3.630

8.  Associations of Cardiovascular Agents and Metformin with Depression Symptoms: A Cross-Sectional Analysis from the HUNT Study, Norway.

Authors:  Ivana Bojanić; Ottar Bjerkeset; Lana J Williams; Michael Berk; Erik R Sund; Hege Sletvold
Journal:  Drugs Real World Outcomes       Date:  2022-07-18

9.  Estimation of Input Costs for a Markov Model in a German Health Economic Evaluation of Newer Antidepressants.

Authors:  Astrid Seidl; Marion Danner; Christoph J Wagner; Frank G Sandmann; Gaby Sroczynski; Heidi Stürzlinger; Johannes Zsifkovits; Anja Schwalm; Stefan K Lhachimi; Uwe Siebert; Andreas Gerber-Grote
Journal:  MDM Policy Pract       Date:  2018-01-10

10.  Persistent depressive disorder across the adult lifespan: results from clinical and population-based surveys in Germany.

Authors:  Julia Nübel; Anne Guhn; Susanne Müllender; Hong Duyen Le; Caroline Cohrdes; Stephan Köhler
Journal:  BMC Psychiatry       Date:  2020-02-10       Impact factor: 3.630

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.